Böpple
Team Leader, Robert Bosch Gesellschaft für medizinische Forschung mbH

Dr. Kathrin Baader Böpple

mobile: +49-173-467 2336

Tel +49-711-8101 2059

Major Projects

  • ProCell for Patient
  • Qualified Person and Deputy Head of Quality Control of Blood Products

Curriculum Vitae

Education and Professional Career

Since 2023

Team Leader, Robert Bosch Gesellschaft für medizinische Forschung, Stuttgart, Germany

Since 2023

Qualified Person (§ 14 AMG), Dept. of Blood Products, Stem Cell and Donor Lymphocyte Manufacturing, Robert Bosch Hospital, Stuttgart, Germany

2022-2023

Training as Qualified Person, Dept. of Blood Products, Stem Cell and Donor Lymphocyte Manufacturing, Robert Bosch Hospital, Stuttgart, Germany

02/2021

Dr. rer nat. in Technical Biology, University Stuttgart, Germany
Thesis: „Characterization of persister-cell derived ovarian cancer cells and methods for advanced 3D cell and tissue culture“

Since 2021

Deputy Head of Quality Control, Dept. of Blood Products, Stem Cell and Donor Lymphocyte Manufacturing, Robert Bosch Hospital, Stuttgart, Germany

2020-2023

Scientific Project Manager, Robert Bosch Gesellschaft für medizinische Forschung, Stuttgart, Germany

2020-2021

Training as Head of Quality Control, Dept. of Blood Products, Stem Cell and Donor Lymphocyte Manufacturing, Robert Bosch Hospital, Stuttgart, Germany

2017-2020

Doctoral thesis, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tübingen, Stuttgart, Germany

01-03/2019

Visiting Scientist/PhD student in the laboratory of Prof. Moshe Oren, Weizmann Institute of Science, Rehovot, Israel

2014-2017

M. Sc. Technical Biology, University Stuttgart, Germany
Thesis: „Human peptides as modulators of infection and latency of the Epstein-Barr-Virus“

2011-2014

B. Sc. Biological Sciences, University Konstanz, Germany
Thesis: „The impact of methylphenidate on the olfactory memory of Drosophila Larvae”

Professional Memberships

Since 2018: Member of European Association for Cancer Research (EACR)
Since 2018: Member of American Association for Cancer Research (AACR)
Since 2024: Member of International Society for Pharmaceutical Engineering (ISPE)
Since 2025: Member of Parenteral Drug Association (PDA)